Stay updated on Clinical Trial: Salvage Therapies in NK/T Cell Lymphoma

Sign up to get notified when there's something new on the Clinical Trial: Salvage Therapies in NK/T Cell Lymphoma page.
Latest website image capture
Clouds background image

Latest updates to the Clinical Trial: Salvage Therapies in NK/T Cell Lymphoma page

  1. Check
    today
    Change Detected
    Summary
    The new screenshot shows the same study details (PD-1 pembrolizumab in relapsed/refractory NK/T cell lymphoma) with only minor layout and labeling differences; there are no changes to core content such as enrollment, primary outcomes, or eligibility criteria. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2025-11-03T21:22:45.000Z thumbnail image
  2. Check
    7 days ago
    No Change Detected
  3. Check
    29 days ago
    Change Detected
    Summary
    Major addition of a government funding notice and upgrade to v3.2.0, replacing v3.1.0; references to operating status and status inquiries are now present.
    Difference
    5%
    Check dated 2025-10-06T05:59:34.000Z thumbnail image
  4. Check
    36 days ago
    Change Detected
    Summary
    Updated terminology and versioning: standardizes the condition name to NK/T cell lymphoma and updates the page from v3.0.2 to v3.1.0, plus addition of contact-like identifiers.
    Difference
    0.4%
    Check dated 2025-09-29T03:13:54.000Z thumbnail image
  5. Check
    50 days ago
    Change Detected
    Summary
    Revision updated to v3.0.2; Back to Top removed. No changes to core content or critical information.
    Difference
    0.3%
    Check dated 2025-09-14T19:55:43.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. Additionally, a 'Back to Top' feature has been added for improved navigation.
    Difference
    0.3%
    Check dated 2025-09-07T16:53:43.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    The page has undergone significant updates, including the addition of a facility name and location, as well as the introduction of specific lymphoma-related terms and the drug pembrolizumab. Notably, the previous version's detailed medical topics and terms have been largely removed.
    Difference
    6%
    Check dated 2025-08-31T12:06:08.000Z thumbnail image

Stay in the know with updates to Clinical Trial: Salvage Therapies in NK/T Cell Lymphoma

Enter your email address, and we'll notify you when there's something new on the Clinical Trial: Salvage Therapies in NK/T Cell Lymphoma page.